Top 100 Contractors in NAICS 325414: Biological Product (except Diagnostic) Manufacturing, FY2023

Parent companies by net contract obligations Oct 1, 2022 – Sep 30, 2023 Code page on GovTribe

The top 10 won 83% of FY2023 NAICS 325414 contract dollars

Ranking facts

Contract obligations
$168,086,512 Net of deobligations, by contracts coded NAICS 325414
Contractors
162 Parent companies with an obligation
Largest contractor
Emergent Biosolutions Inc. $121 million, 38.9% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $120,978,257
Rank history: #4 in FY2021, #4 in FY2022 and not on the FY2024–FY2025 lists; up 3 since FY2022.
2
Modernatx Inc.
$47,744,136
Rank history: #3 in FY2021, #2 in FY2022 and not on the FY2024–FY2025 lists; unchanged since FY2022.
3 $44,335,331
Rank history: #26 in FY2021, #3 in FY2022, #6 in FY2024 and #10 in FY2025; unchanged since FY2022.
4
Boehringer Ingelheim Corporation Through Boehringer Ingelheim Animal Health France
$14,362,500
Rank history: #8 in FY2021, #6 in FY2022 and not on the FY2024–FY2025 lists; up 2 since FY2022.
5
VALNEVA Through Valneva Usa, Inc.
$9,609,600
Rank history: #6 in FY2021, #5 in FY2022, #7 in FY2024 and not on the FY2025 list; unchanged since FY2022.
6 $6,466,593
Rank history: #17 in FY2021, #9 in FY2022, #24 in FY2024 and not on the FY2025 list; up 3 since FY2022.
7 $5,548,113
Rank history: #28 in FY2021, #23 in FY2022, #10 in FY2024 and #6 in FY2025; up 16 since FY2022.
8 $4,507,399
Rank history: #13 in FY2021, #8 in FY2022, #12 in FY2024 and #7 in FY2025; unchanged since FY2022.
9 $3,087,500
Rank history: #14 in FY2021, #18 in FY2022, not on the FY2024 list and #11 in FY2025; up 9 since FY2022.
10 $2,509,177
Rank history: #19 in FY2021, #13 in FY2022, #17 in FY2024 and #17 in FY2025; up 3 since FY2022.
11 $2,347,701
Rank history: #18 in FY2021, #10 in FY2022, #13 in FY2024 and #12 in FY2025; down 1 since FY2022.
12 $2,189,192
Rank history: #12 in FY2021, #7 in FY2022, #52 in FY2024 and not on the FY2025 list; down 5 since FY2022.
13
Glaxosmithkline LLC
$2,059,410
Rank history: #21 in FY2021, #79 in FY2022, #4 in FY2024 and #3 in FY2025; up 66 since FY2022.
14 $1,278,000
Rank history: #24 in FY2021, #16 in FY2022, #18 in FY2024 and #45 in FY2025; up 2 since FY2022.
15 $900,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
16 $817,654
Rank history: not on the FY2021–FY2022 lists, #41 in FY2024 and #36 in FY2025; new.
17 $755,868
Rank history: #47 in FY2021, #21 in FY2022, #40 in FY2024 and not on the FY2025 list; up 4 since FY2022.
18 $731,586
Rank history: #60 in FY2021, #33 in FY2022 and not on the FY2024–FY2025 lists; up 15 since FY2022.
19 $705,152
Rank history: not on the FY2021 list, #17 in FY2022 and not on the FY2024–FY2025 lists; down 2 since FY2022.
20 $662,954
Rank history: #39 in FY2021, #24 in FY2022 and not on the FY2024–FY2025 lists; up 4 since FY2022.
21 $658,825
Rank history: #30 in FY2021, #94 in FY2022, #19 in FY2024 and #13 in FY2025; up 73 since FY2022.
22 $599,534
Rank history: #33 in FY2021, #27 in FY2022, not on the FY2024 list and #27 in FY2025; up 5 since FY2022.
23 $571,010
Rank history: #53 in FY2021, not on the FY2022 list, #49 in FY2024 and #22 in FY2025; returned.
24 $548,539
Rank history: #35 in FY2021, #22 in FY2022, #45 in FY2024 and #48 in FY2025; down 2 since FY2022.
25 $473,094
Rank history: #57 in FY2021, #35 in FY2022, #32 in FY2024 and not on the FY2025 list; up 10 since FY2022.
26
Mattek Corporation
$469,549
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
27 $384,398
Rank history: #15 in FY2021, #30 in FY2022, #46 in FY2024 and #39 in FY2025; up 3 since FY2022.
28 $365,573
Rank history: #34 in FY2021, #34 in FY2022, #20 in FY2024 and not on the FY2025 list; up 6 since FY2022.
29 $350,000
Rank history: #36 in FY2021, not on the FY2022 list and not on the FY2024–FY2025 lists; returned.
30 $328,824
Rank history: #61 in FY2021, #49 in FY2022, #43 in FY2024 and not on the FY2025 list; up 19 since FY2022.
31 $312,930
Rank history: not on the FY2021 list, #31 in FY2022, #22 in FY2024 and #50 in FY2025; unchanged since FY2022.
32 $307,952
Rank history: #93 in FY2021, #63 in FY2022 and not on the FY2024–FY2025 lists; up 31 since FY2022.
33 $287,269
Rank history: not on the FY2021 list, #64 in FY2022 and not on the FY2024–FY2025 lists; up 31 since FY2022.
34 $284,219
Rank history: #56 in FY2021, #42 in FY2022, #35 in FY2024 and #34 in FY2025; up 8 since FY2022.
35 $275,910
Rank history: #27 in FY2021, #25 in FY2022, #42 in FY2024 and not on the FY2025 list; down 10 since FY2022.
36 $265,570
Rank history: #44 in FY2021, #36 in FY2022, #33 in FY2024 and not on the FY2025 list; unchanged since FY2022.
37 $263,721
Rank history: #72 in FY2021, #15 in FY2022, #51 in FY2024 and #99 in FY2025; down 22 since FY2022.
38 $249,965
Rank history: not on the FY2021 list, #37 in FY2022, #34 in FY2024 and #38 in FY2025; down 1 since FY2022.
39
Cell Microsystems Inc
$249,662
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
40 $249,630
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
41
Olink Proteomics Inc
$246,214
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
42 $245,024
Rank history: #41 in FY2021, #39 in FY2022, #54 in FY2024 and #79 in FY2025; down 3 since FY2022.
43 $240,750
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
44 $236,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
45 $233,782
Rank history: #75 in FY2021, #66 in FY2022, #47 in FY2024 and #44 in FY2025; up 21 since FY2022.
46 $227,550
Rank history: #16 in FY2021, #12 in FY2022, #36 in FY2024 and #75 in FY2025; down 34 since FY2022.
47 $224,000
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
48 $197,270
Rank history: #88 in FY2021, #32 in FY2022, #23 in FY2024 and #30 in FY2025; down 16 since FY2022.
49
Horizon Discovery Biosciences Limited
$188,854
Rank history: #64 in FY2021, #92 in FY2022 and not on the FY2024–FY2025 lists; up 43 since FY2022.
50
Olink Proteomics AB
$179,738
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
51 $169,723
Rank history: #31 in FY2021, #44 in FY2022 and not on the FY2024–FY2025 lists; down 7 since FY2022.
52 $167,262
Rank history: not on the FY2021 list, #68 in FY2022, not on the FY2024 list and #42 in FY2025; up 16 since FY2022.
53 $163,872
Rank history: #50 in FY2021, #67 in FY2022, #50 in FY2024 and #56 in FY2025; up 14 since FY2022.
54 $149,535
Rank history: not on the FY2021–FY2022 lists, not on the FY2024 list and #65 in FY2025; new.
55 $145,144
Rank history: #62 in FY2021, #46 in FY2022, #53 in FY2024 and #51 in FY2025; down 9 since FY2022.
56 $132,380
Rank history: not on the FY2021 list, #95 in FY2022, #67 in FY2024 and #62 in FY2025; up 39 since FY2022.
57 $132,289
Rank history: not on the FY2021–FY2022 lists, #80 in FY2024 and #60 in FY2025; new.
58 $128,740
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
59 $125,910
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
60 $121,853
Rank history: not on the FY2021 list, #98 in FY2022 and not on the FY2024–FY2025 lists; up 38 since FY2022.
61 $121,758
Rank history: #63 in FY2021, #58 in FY2022 and not on the FY2024–FY2025 lists; down 3 since FY2022.
62 $115,816
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
63 $111,373
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
64 $104,708
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
65 $102,900
Rank history: #52 in FY2021, #38 in FY2022, #38 in FY2024 and #53 in FY2025; down 27 since FY2022.
66 $98,600
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
67
Invivotek LLC
$98,571
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
68 $97,757
Rank history: #83 in FY2021, #61 in FY2022 and not on the FY2024–FY2025 lists; down 7 since FY2022.
69
The Children'S Hospital of Philadelphia Foundation Through The Children's Hospital of Philadelphia
$96,866
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
70
Emergency Physicians Medical Group P.C. Through LGC Clinical Diagnostics Inc.
$94,147
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
71 $93,257
Rank history: not on the FY2021 list, #85 in FY2022, #62 in FY2024 and not on the FY2025 list; up 14 since FY2022.
72 $89,665
Rank history: #68 in FY2021, #53 in FY2022, #31 in FY2024 and #49 in FY2025; down 19 since FY2022.
73 $77,874
Rank history: not on the FY2021 list, #57 in FY2022 and not on the FY2024–FY2025 lists; down 16 since FY2022.
74 $75,600
Rank history: not on the FY2021 list, #51 in FY2022, not on the FY2024 list and #58 in FY2025; down 23 since FY2022.
75
DNA Twopointo Inc.
$75,000
Rank history: not on the FY2021–FY2022 lists, #74 in FY2024 and #64 in FY2025; new.
76 $74,691
Rank history: not on the FY2021 list, #60 in FY2022 and not on the FY2024–FY2025 lists; down 16 since FY2022.
77 $73,300
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
78 $71,791
Rank history: #43 in FY2021, #43 in FY2022 and not on the FY2024–FY2025 lists; down 35 since FY2022.
79
Stago International Through Diagnostica Stago Inc.
$71,649
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
80
Merck KG AUF Aktien 2 awardees, including Sigma-Aldrich, Inc. and EMD Millipore Corp
$71,012
Rank history: #77 in FY2021, #69 in FY2022 and not on the FY2024–FY2025 lists; down 11 since FY2022.
81 $70,447
Rank history: #69 in FY2021, #56 in FY2022, #59 in FY2024 and not on the FY2025 list; down 25 since FY2022.
82 $65,500
Rank history: not on the FY2021–FY2022 lists, #61 in FY2024 and not on the FY2025 list; new.
83 $63,608
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
84
A B C a M PLC Through Abcam Inc.
$59,643
Rank history: #97 in FY2021, #75 in FY2022 and not on the FY2024–FY2025 lists; down 9 since FY2022.
85 $57,645
Rank history: #99 in FY2021, #78 in FY2022, #100 in FY2024 and not on the FY2025 list; down 7 since FY2022.
86
Cambridge Isotope Laboratories Inc.
$57,624
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 57 since FY2022.
87
Pine Pharmaceuticals LLC
$57,187
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
88 $51,380
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
89 $49,394
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
90 $49,248
Rank history: not on the FY2021 list, #82 in FY2022 and not on the FY2024–FY2025 lists; down 8 since FY2022.
91 $47,800
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
92 $46,410
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 42 since FY2022.
93 $43,197
Rank history: #48 in FY2021, not on the FY2022 list and not on the FY2024–FY2025 lists; up 18 since FY2022.
94
Oxford Nanopore Technologies PLC
$42,885
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
95 $40,530
Rank history: not on the FY2021 list, #89 in FY2022, not on the FY2024 list and #98 in FY2025; down 6 since FY2022.
96 $39,400
Rank history: not on the FY2021 list, #70 in FY2022, #83 in FY2024 and #54 in FY2025; down 26 since FY2022.
97 $37,130
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; up 29 since FY2022.
98 $37,000
Rank history: not on the FY2021 list, #100 in FY2022 and not on the FY2024–FY2025 lists; up 2 since FY2022.
100 $34,577
Rank history: not on the FY2021–FY2022 lists and not on the FY2024–FY2025 lists; new.
Show 75 more

100 of 162 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $311 million obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2023 ran Oct 1, 2022 – Sep 30, 2023. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2022. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2022 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 325414 contractors in FY2023?

1. Emergent Biosolutions Inc. ($121M), 2. Modernatx Inc. ($47.7M), 3. Seqirus USA Inc. ($44.3M), 4. Boehringer Ingelheim Corporation ($14.4M), 5. VALNEVA ($9.61M), 6. SANOFI ($6.47M), 7. Boehringer Ingelheim Animal Health USA Inc ($5.55M), 8. The American National Red Cross ($4.51M), 9. Biogenesis Bago S.A. ($3.09M), 10. 10X Genomics, Inc. ($2.51M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work